A Theranostic and Precision Medicine Approach for Female-Specific Cancers

A Theranostic and Precision Medicine Approach for Female-Specific Cancers provides information regarding ongoing research and clinical data surrounding female specific cancers (breast, cervical, ovarian and endometrial cancers). The book encompasses detailed descriptions about diagnostics and therapeutic options for easy understanding, focusing on the subject matter with a broader range of treatment options. In addition, it explores new theranostics, i.e., diagnostic, therapeutic and precision medicine strategies currently being developed for FSCs. This book is a valuable resource for cancer researchers, clinicians, graduate students and other members of biomedical field who need to understand the most recent and promising approaches to manage FSCs.

Explores new diagnostic biomarkers surrounding the early detection and prognosis of FSCsExamines new genetic and molecularly targeted approaches for the treatment of these aggressive diseases Discusses new theranostic approaches that combine diagnosis and treatment through the use of nanotechnology in FSCs Addresses how these various advances can be integrated into a precision and personalized medicine approach that can eventually enhance patient care

1. Overview of female specific cancer biology
2. Circulating biomarkers for early diagnosis of FSCs
3. Epigenetic biomarkers for the detection of FSCs
4. Chemotherapy resistance mechanisms in FSCs
5. Gene alterations with chemotherapy in FSCs
6. Small molecule-targeted therapies for FSCs: success and failures
7. Immunotherapies for FSCs
8. Nanotechnology-based therapeutic approaches for FSCs: combining diagnosis and treatment
9. Towards a personalized medicine approach for the treatment of FSCs